
Results
34
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
34 companies
InSilico Medicine Cayman TopCo
Market Cap: HK$23.7b
Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.
3696
HK$39.42
7D
-14.3%
1Y
n/a
Bonesupport Holding
Market Cap: SEK 14.7b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 223.60
7D
-0.7%
1Y
-22.1%
Tecan Group
Market Cap: CHF 2.3b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 189.10
7D
4.4%
1Y
10.7%
AstraZeneca
Market Cap: UK£183.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£118.06
7D
-0.3%
1Y
0.2%
Natera
Market Cap: US$45.3b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$311.69
7D
-0.3%
1Y
94.7%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €200.9m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.54
7D
0.9%
1Y
-0.9%
CanSino Biologics
Market Cap: HK$10.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$23.34
7D
-5.4%
1Y
-50.8%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.00
7D
-0.6%
1Y
1.0%
Hyphens Pharma International
Market Cap: S$112.8m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.37
7D
-1.3%
1Y
27.6%
Almirall
Market Cap: €2.3b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€10.50
7D
-2.1%
1Y
-5.7%
Xeris Biopharma Holdings
Market Cap: US$1.6b
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$8.85
7D
5.5%
1Y
20.2%
Pangaea Oncology
Market Cap: €55.7m
A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.
PANG
€1.55
7D
0%
1Y
-9.9%
Renata
Market Cap: ৳53.8b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.
RENATA
৳469.10
7D
-0.9%
1Y
-5.0%
Galderma Group
Market Cap: CHF 39.5b
Operates as a dermatology company worldwide.
GALD
CHF 169.60
7D
-3.6%
1Y
25.4%
Bora Pharmaceuticals
Market Cap: NT$51.5b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$404.50
7D
-4.5%
1Y
-47.7%
Teva Pharmaceutical Industries
Market Cap: US$42.5b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$36.58
7D
0.3%
1Y
108.3%
Mesoblast
Market Cap: AU$3.1b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.40
7D
-0.4%
1Y
0.8%
AbbVie
Market Cap: US$442.4b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$258.92
7D
3.5%
1Y
25.6%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.8b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€52.55
7D
-0.3%
1Y
0.5%
Innovent Biologics
Market Cap: HK$168.3b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$98.25
7D
2.8%
1Y
3.8%
Chugai Pharmaceutical
Market Cap: JP¥11.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,847.00
7D
-3.7%
1Y
4.7%
CSPC Innovation Pharmaceutical
Market Cap: CN¥61.8b
Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.
300765
CN¥44.40
7D
2.5%
1Y
-9.2%
Aroa Biosurgery
Market Cap: AU$200.6m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.58
7D
-4.1%
1Y
-6.5%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.51
7D
-3.1%
1Y
14.5%
Merck
Market Cap: US$335.5b
Operates as a healthcare company worldwide.
MRK
US$135.17
7D
3.6%
1Y
59.2%
hVIVO
Market Cap: UK£45.3m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.066
7D
-4.3%
1Y
-35.6%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$62.1b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$60.45
7D
-9.9%
1Y
169.9%
Ligand Pharmaceuticals
Market Cap: US$5.8b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$287.59
7D
-0.4%
1Y
86.7%
BioGaia
Market Cap: SEK 11.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.60
7D
3.0%
1Y
20.7%
Selvita
Market Cap: zł513.0m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł27.95
7D
-1.9%
1Y
-15.6%
Strides Pharma Science
Market Cap: ₹87.5b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹949.10
7D
-5.4%
1Y
9.2%
Viyash Scientific
Market Cap: ₹111.1b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹254.65
7D
-2.6%
1Y
44.3%
WuXi XDC Cayman
Market Cap: HK$88.5b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$68.05
7D
6.5%
1Y
18.0%
L&C BIOLTD
Market Cap: ₩1.4t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩52,800.00
7D
-16.9%
1Y
70.9%